 Sarah Sasse
Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Glucocorticoid | 13 | 2025 | 130 | 3.390 |
Why?
| | Dexamethasone | 9 | 2022 | 366 | 1.970 |
Why?
| | Transcription, Genetic | 9 | 2025 | 1468 | 1.450 |
Why?
| | Glucocorticoids | 7 | 2025 | 531 | 1.350 |
Why?
| | NF-kappa B | 9 | 2025 | 660 | 1.230 |
Why?
| | Kruppel-Like Transcription Factors | 4 | 2020 | 79 | 1.170 |
Why?
| | Enhancer Elements, Genetic | 5 | 2025 | 192 | 1.120 |
Why?
| | Muscle, Smooth | 3 | 2019 | 153 | 1.080 |
Why?
| | Tumor Necrosis Factor-alpha | 7 | 2025 | 1212 | 0.980 |
Why?
| | Nuclear Proteins | 3 | 2017 | 743 | 0.740 |
Why?
| | Gene Expression Regulation | 11 | 2025 | 2594 | 0.740 |
Why?
| | Asthma | 4 | 2026 | 1795 | 0.620 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 478 | 0.610 |
Why?
| | RNA | 2 | 2025 | 929 | 0.580 |
Why?
| | Cytokines | 4 | 2025 | 2054 | 0.560 |
Why?
| | Proline Oxidase | 2 | 2015 | 6 | 0.550 |
Why?
| | Hyperoxia | 1 | 2019 | 96 | 0.550 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 3 | 2016 | 12 | 0.540 |
Why?
| | Response Elements | 2 | 2015 | 86 | 0.530 |
Why?
| | Phospholipase C delta | 1 | 2017 | 5 | 0.530 |
Why?
| | Epithelial Cells | 7 | 2026 | 1112 | 0.530 |
Why?
| | Airway Obstruction | 1 | 2019 | 154 | 0.520 |
Why?
| | Habituation, Psychophysiologic | 4 | 2011 | 58 | 0.510 |
Why?
| | Airway Remodeling | 1 | 2017 | 63 | 0.500 |
Why?
| | Respiratory System | 2 | 2017 | 151 | 0.500 |
Why?
| | RNA, Messenger | 6 | 2025 | 2820 | 0.460 |
Why?
| | Saccharopine Dehydrogenases | 1 | 2015 | 3 | 0.460 |
Why?
| | Corticosterone | 5 | 2010 | 242 | 0.430 |
Why?
| | Inflammation | 5 | 2026 | 2883 | 0.430 |
Why?
| | Stress, Psychological | 7 | 2011 | 1153 | 0.410 |
Why?
| | Idiopathic Pulmonary Fibrosis | 4 | 2025 | 691 | 0.410 |
Why?
| | Wood | 2 | 2026 | 21 | 0.400 |
Why?
| | Transcription Factor RelA | 3 | 2025 | 85 | 0.390 |
Why?
| | Receptors, Aryl Hydrocarbon | 2 | 2025 | 60 | 0.380 |
Why?
| | Adrenocorticotropic Hormone | 4 | 2010 | 147 | 0.380 |
Why?
| | Acoustic Stimulation | 5 | 2011 | 333 | 0.380 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 207 | 0.380 |
Why?
| | Smoke | 2 | 2026 | 148 | 0.370 |
Why?
| | Transcription Factors | 3 | 2022 | 1733 | 0.330 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2026 | 2146 | 0.320 |
Why?
| | Fatty Acid-Binding Proteins | 3 | 2026 | 79 | 0.320 |
Why?
| | Signal Transduction | 6 | 2021 | 5202 | 0.310 |
Why?
| | Pituitary-Adrenal System | 5 | 2010 | 163 | 0.300 |
Why?
| | DNA-Binding Proteins | 3 | 2014 | 1487 | 0.290 |
Why?
| | Hypothalamo-Hypophyseal System | 5 | 2010 | 196 | 0.290 |
Why?
| | Mucin-5B | 3 | 2022 | 234 | 0.280 |
Why?
| | Motor Activity | 3 | 2011 | 723 | 0.270 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2026 | 456 | 0.270 |
Why?
| | Lung | 7 | 2025 | 4103 | 0.260 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2026 | 919 | 0.260 |
Why?
| | Genomics | 3 | 2022 | 834 | 0.260 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2017 | 139 | 0.250 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 266 | 0.250 |
Why?
| | A549 Cells | 5 | 2025 | 75 | 0.250 |
Why?
| | Binding Sites | 4 | 2021 | 1313 | 0.240 |
Why?
| | Interferon Regulatory Factor-1 | 1 | 2025 | 17 | 0.240 |
Why?
| | Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2025 | 4 | 0.230 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2025 | 45 | 0.230 |
Why?
| | Interferon Regulatory Factors | 1 | 2025 | 44 | 0.230 |
Why?
| | Bronchi | 2 | 2018 | 263 | 0.220 |
Why?
| | Protein Binding | 5 | 2020 | 2250 | 0.210 |
Why?
| | I-kappa B Kinase | 1 | 2024 | 51 | 0.210 |
Why?
| | Respiratory Mucosa | 3 | 2025 | 322 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 4 | 2026 | 2355 | 0.200 |
Why?
| | Particulate Matter | 2 | 2026 | 337 | 0.200 |
Why?
| | Humans | 26 | 2026 | 145491 | 0.190 |
Why?
| | Macrophages, Alveolar | 1 | 2026 | 368 | 0.190 |
Why?
| | Cells, Cultured | 4 | 2018 | 4127 | 0.180 |
Why?
| | RNA Polymerase II | 4 | 2021 | 351 | 0.180 |
Why?
| | Cell Line | 5 | 2025 | 2823 | 0.180 |
Why?
| | Chromatin | 3 | 2022 | 555 | 0.180 |
Why?
| | Animals | 15 | 2026 | 38141 | 0.170 |
Why?
| | Models, Genetic | 2 | 2021 | 531 | 0.170 |
Why?
| | Promoter Regions, Genetic | 3 | 2017 | 1247 | 0.170 |
Why?
| | Alveolar Epithelial Cells | 1 | 2022 | 120 | 0.170 |
Why?
| | Air Pollution | 1 | 2025 | 321 | 0.170 |
Why?
| | Stress, Physiological | 3 | 2010 | 452 | 0.170 |
Why?
| | PPAR gamma | 1 | 2022 | 178 | 0.170 |
Why?
| | Toll-Like Receptor 2 | 1 | 2022 | 127 | 0.170 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 265 | 0.160 |
Why?
| | Membrane Proteins | 1 | 2026 | 1164 | 0.150 |
Why?
| | Interleukin-1beta | 3 | 2025 | 390 | 0.140 |
Why?
| | Fluticasone | 1 | 2018 | 53 | 0.140 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2018 | 26 | 0.140 |
Why?
| | Repressor Proteins | 1 | 2021 | 430 | 0.140 |
Why?
| | Drug Resistance | 1 | 2018 | 146 | 0.130 |
Why?
| | Base Sequence | 3 | 2017 | 2180 | 0.130 |
Why?
| | Hypertrophy | 1 | 2017 | 128 | 0.130 |
Why?
| | Transcriptional Activation | 2 | 2016 | 372 | 0.130 |
Why?
| | Transduction, Genetic | 1 | 2017 | 132 | 0.130 |
Why?
| | Primary Cell Culture | 1 | 2017 | 172 | 0.120 |
Why?
| | HEK293 Cells | 1 | 2019 | 743 | 0.120 |
Why?
| | Cellular Senescence | 1 | 2019 | 225 | 0.120 |
Why?
| | Genes, Reporter | 1 | 2017 | 276 | 0.120 |
Why?
| | Trachea | 1 | 2018 | 258 | 0.120 |
Why?
| | Adenoviridae | 1 | 2017 | 199 | 0.120 |
Why?
| | Amygdala | 2 | 2009 | 199 | 0.120 |
Why?
| | Gene Silencing | 1 | 2016 | 202 | 0.110 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 482 | 0.110 |
Why?
| | Fibroblasts | 2 | 2025 | 1023 | 0.110 |
Why?
| | Interferon-gamma | 1 | 2018 | 782 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 6 | 2011 | 2526 | 0.110 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 88 | 0.110 |
Why?
| | Rats | 8 | 2011 | 5581 | 0.110 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 443 | 0.110 |
Why?
| | Transforming Growth Factor beta | 1 | 2017 | 475 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 667 | 0.110 |
Why?
| | Cohort Studies | 1 | 2025 | 5992 | 0.100 |
Why?
| | Male | 11 | 2025 | 72817 | 0.100 |
Why?
| | Introns | 1 | 2014 | 256 | 0.090 |
Why?
| | Mice, Knockout | 2 | 2026 | 3125 | 0.090 |
Why?
| | Mice | 4 | 2026 | 18338 | 0.090 |
Why?
| | Noise | 3 | 2011 | 72 | 0.090 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 320 | 0.090 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 553 | 0.090 |
Why?
| | Physical Conditioning, Animal | 2 | 2011 | 242 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2910 | 0.080 |
Why?
| | Transcriptome | 1 | 2017 | 1038 | 0.080 |
Why?
| | Nerve Growth Factors | 1 | 2010 | 78 | 0.080 |
Why?
| | Body Temperature | 1 | 2011 | 227 | 0.080 |
Why?
| | Dentate Gyrus | 1 | 2010 | 41 | 0.080 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2010 | 45 | 0.080 |
Why?
| | Escape Reaction | 1 | 2009 | 55 | 0.080 |
Why?
| | Olfactory Pathways | 1 | 2009 | 38 | 0.070 |
Why?
| | Olfactory Perception | 1 | 2009 | 18 | 0.070 |
Why?
| | Analysis of Variance | 5 | 2010 | 1304 | 0.070 |
Why?
| | Middle Aged | 2 | 2025 | 36176 | 0.070 |
Why?
| | Adrenal Glands | 1 | 2008 | 76 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 839 | 0.070 |
Why?
| | Female | 4 | 2025 | 78763 | 0.070 |
Why?
| | Organ Size | 1 | 2008 | 461 | 0.070 |
Why?
| | Thymus Gland | 1 | 2008 | 311 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2019 | 6437 | 0.060 |
Why?
| | Heart Rate | 1 | 2011 | 859 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2022 | 672 | 0.060 |
Why?
| | Haemophilus Infections | 1 | 2026 | 45 | 0.060 |
Why?
| | Radioimmunoassay | 3 | 2010 | 165 | 0.060 |
Why?
| | Haemophilus influenzae | 1 | 2026 | 67 | 0.060 |
Why?
| | DNA Methylation | 2 | 2022 | 667 | 0.060 |
Why?
| | Interleukin-8 | 1 | 2026 | 269 | 0.050 |
Why?
| | Gene Expression | 2 | 2022 | 1478 | 0.050 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2025 | 191 | 0.050 |
Why?
| | Neural Inhibition | 1 | 2005 | 178 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2026 | 441 | 0.050 |
Why?
| | Desmoplakins | 1 | 2022 | 24 | 0.050 |
Why?
| | Transposases | 1 | 2022 | 19 | 0.050 |
Why?
| | Afghanistan | 1 | 2022 | 96 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2025 | 383 | 0.040 |
Why?
| | Budesonide | 1 | 2022 | 49 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5989 | 0.040 |
Why?
| | Cytochrome P-450 CYP1A1 | 1 | 2021 | 9 | 0.040 |
Why?
| | Adult | 1 | 2025 | 40707 | 0.040 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2021 | 36 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2021 | 138 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2021 | 147 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 34 | 0.040 |
Why?
| | Respiratory Tract Diseases | 1 | 2022 | 176 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 56 | 0.040 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 108 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 375 | 0.040 |
Why?
| | Ferrets | 2 | 2009 | 31 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 975 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 573 | 0.040 |
Why?
| | Young Adult | 1 | 2016 | 14192 | 0.040 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 205 | 0.040 |
Why?
| | Odorants | 2 | 2009 | 115 | 0.040 |
Why?
| | Smell | 2 | 2009 | 127 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 536 | 0.030 |
Why?
| | Th1 Cells | 1 | 2018 | 139 | 0.030 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 12 | 0.030 |
Why?
| | Restraint, Physical | 2 | 2010 | 75 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 187 | 0.030 |
Why?
| | In Situ Hybridization | 2 | 2010 | 318 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 161 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2009 | 196 | 0.030 |
Why?
| | Adolescent | 1 | 2016 | 22485 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 335 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2862 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1451 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 632 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 473 | 0.030 |
Why?
| | Macrophages | 1 | 2022 | 1509 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2030 | 0.030 |
Why?
| | Behavior, Animal | 2 | 2009 | 526 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1162 | 0.020 |
Why?
| | Environment, Controlled | 1 | 2010 | 23 | 0.020 |
Why?
| | Zinc Sulfate | 1 | 2009 | 8 | 0.020 |
Why?
| | Vomeronasal Organ | 1 | 2009 | 9 | 0.020 |
Why?
| | Ibotenic Acid | 1 | 2009 | 5 | 0.020 |
Why?
| | Dominance-Subordination | 1 | 2009 | 16 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 10874 | 0.020 |
Why?
| | Cell Count | 1 | 2009 | 320 | 0.020 |
Why?
| | Olfaction Disorders | 1 | 2009 | 70 | 0.020 |
Why?
| | Running | 1 | 2011 | 230 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1710 | 0.010 |
Why?
| | Early Growth Response Protein 1 | 1 | 2005 | 32 | 0.010 |
Why?
| | Paraventricular Hypothalamic Nucleus | 1 | 2005 | 34 | 0.010 |
Why?
| | Amphetamine | 1 | 2005 | 38 | 0.010 |
Why?
| | Immediate-Early Proteins | 1 | 2005 | 46 | 0.010 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2005 | 140 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11837 | 0.010 |
Why?
| | Central Nervous System Stimulants | 1 | 2005 | 185 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2010 | 4559 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 7171 | 0.010 |
Why?
| | Child | 1 | 2018 | 22680 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1815 | 0.010 |
Why?
|
|
Sasse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|